Literature DB >> 14960298

High nitric oxide production in autistic disorder: a possible role for interferon-gamma.

Thayne L Sweeten1, David J Posey, Sudha Shankar, Christopher J McDougle.   

Abstract

BACKGROUND: Neuroimmune regulation abnormalities have been implicated in the pathophysiology of autistic disorder. Nitric oxide (NO) is involved in immune reactivity and is known to affect brain neurodevelopmental processes. Recent evidence indicates that NO, and cytokines involved in NO production, may be high in children with autism. The purpose of this study was to verify that plasma NO is high in children with autism and determine whether this elevation is related to plasma levels of cytokines involved in NO production.
METHODS: The metabolites of NO, nitrite, and nitrate (NOx), along with the cytokines interferon-gamma (IFN-gamma), tumor necrosis factor-alpha, and interleukin-1beta, were measured in plasma of 29 children with autism (mean age +/- SD = 6.1 +/- 2.8 years) and 27 age- and gender-matched healthy comparison subjects using commercially available assay kits.
RESULTS: Plasma levels of NOx were significantly higher in the autistic subjects (p =.006); plasma levels of the cytokines did not differ between groups. NOx and IFN-gamma levels were positively correlated in the autistic subjects (r =.51; p =.005).
CONCLUSIONS: These results confirm that plasma NO is high in some children with autism and suggest that this elevation may be related to IFN-gamma activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14960298     DOI: 10.1016/j.biopsych.2003.09.001

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  55 in total

1.  Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.

Authors:  Zuzana Tobiasova; Klaas H B van der Lingen; Lawrence Scahill; James F Leckman; Yan Zhang; Wookjin Chae; James T McCracken; Christopher J McDougle; Benedetto Vitiello; Elaine Tierney; Michael G Aman; L Eugene Arnold; Liliya Katsovich; Pieter J Hoekstra; Fred Volkmar; Alfred L M Bothwell; Ivana Kawikova
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-11-09       Impact factor: 2.576

2.  A Stability-Indicating HPLC Method for the Determination of Nitrosylcobalamin (NO-Cbl), a Novel Vitamin B12 Analog.

Authors:  Michael J Dunphy; Annette M Sysel; Joseph A Lupica; Kristie Griffith; Taylor Sherrod; Joseph A Bauer
Journal:  Chromatographia       Date:  2014-04-01       Impact factor: 2.044

3.  Cell transplantation as a novel therapeutic strategy for autism spectrum disorders: a clinical study.

Authors:  Alok K Sharma; Nandini Gokulchandran; Pooja P Kulkarni; Hemangi M Sane; Ridhima Sharma; Alitta Jose; Prerna B Badhe
Journal:  Am J Stem Cells       Date:  2020-12-25

4.  Cytokine Profile in Autism Spectrum Disorders in Children.

Authors:  Vesna Bryn; Hans Christian Dalsbotten Aass; Ola H Skjeldal; Jørn Isaksen; Ola Didrik Saugstad; Heidi Ormstad
Journal:  J Mol Neurosci       Date:  2016-10-12       Impact factor: 3.444

Review 5.  Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?

Authors:  Dominika Gładysz; Amanda Krzywdzińska; Kamil K Hozyasz
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

6.  Neonatal Immune Challenge with Lipopolysaccharide Triggers Long-lasting Sex- and Age-related Behavioral and Immune/Neurotrophic Alterations in Mice: Relevance to Autism Spectrum Disorders.

Authors:  Charllyany Sabino Custódio; Bruna Stefânia Ferreira Mello; Adriano José Maia Chaves Filho; Camila Nayane de Carvalho Lima; Rafaela Carneiro Cordeiro; Fábio Miyajima; Gislaine Z Réus; Silvânia Maria Mendes Vasconcelos; Tatiana Barichello; João Quevedo; Antônio Carlos de Oliveira; David Freitas de Lucena; Danielle S Macedo
Journal:  Mol Neurobiol       Date:  2017-05-23       Impact factor: 5.590

Review 7.  Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis.

Authors:  A Masi; D S Quintana; N Glozier; A R Lloyd; I B Hickie; A J Guastella
Journal:  Mol Psychiatry       Date:  2014-06-17       Impact factor: 15.992

Review 8.  Diagnostic and Severity-Tracking Biomarkers for Autism Spectrum Disorder.

Authors:  Geir Bjørklund; Nagwa A Meguid; Afaf El-Ansary; Mona A El-Bana; Maryam Dadar; Jan Aaseth; Maha Hemimi; Joško Osredkar; Salvatore Chirumbolo
Journal:  J Mol Neurosci       Date:  2018-10-24       Impact factor: 3.444

9.  Cortex contacts both output neurons and nitrergic interneurons in the superior colliculus: direct and indirect routes for multisensory integration.

Authors:  Veronica Fuentes-Santamaria; Juan Carlos Alvarado; Barry E Stein; John G McHaffie
Journal:  Cereb Cortex       Date:  2007-11-13       Impact factor: 5.357

Review 10.  Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment.

Authors:  Paula E Goines; Paul Ashwood
Journal:  Neurotoxicol Teratol       Date:  2012-08-17       Impact factor: 3.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.